RB1CC1 acts tumor suppressive in inhibiting cell cycle progression and proliferation by RB1 induction, p53 stabilization, cyclin D1 destabilization, suppression of PyK2 and FAK, and STAT protein inhibition in vitro[34], [35], [36], [37], [38]. The gene discussed is PTK2; the disease is neoplasm.